Isolation, purification and cultivation of conjunctival melanocytes

Experimental Eye Research

Volumn 84, Issue 4, 2007, Pages 655-662

  Hu, Dan Ning ^a   McCormick, Steven A ^a   Seedor, John A ^a   Ritterband, David C ^a   Shah, Mahendra K ^a  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

Author keywords

cell culture; conjunctival melanocytes; conjunctival melanoma; dispase; melanogenesis

Indexed keywords

ANTIBIOTIC G 418; BASIC FIBROBLAST GROWTH FACTOR; CHOLERA TOXIN; CYTOTOXIC AGENT; DISPASE; ISOBUTYLMETHYLXANTHINE; MELANIN; TRYPSIN;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL ISOLATION; CELL VIABILITY; CONJUNCTIVA EPITHELIUM; CONTROLLED STUDY; CULTURE MEDIUM; EYE COLOR; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; MELANOCYTE; MELANOGENESIS; MICRODISSECTION; PIGMENTATION; PRIORITY JOURNAL; PURIFICATION; SERUM;

CELL DIVISION; CELLS, CULTURED; CONJUNCTIVA; CULTURE MEDIA, CONDITIONED; EDETIC ACID; ENDOPEPTIDASES; EPITHELIAL CELLS; EYE COLOR; HUMANS; IMMUNOHISTOCHEMISTRY; MELANINS; MELANOCYTES; MICRODISSECTION; MICROSCOPY, PHASE-CONTRAST; TRYPSIN;

EID: 33947187645     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2006.12.003     Document Type: Article

References (41)

1. Bergman L., Seregard S., Nilsson B., Ringborg U., Lundell G., and Ragnarsson-Olding B. Incidence of uveal melanoma in Sweden from 1960-1998. Invest. Ophthalmol. Vis. Sci. 43 (2002) 2579-2583
2. Brownstein S. Malignant melanoma of the conjunctiva. Cancer Control 11 (2004) 310-316
3. Chen Y.F., Chang J.S., Yang P.Y., Hung C.M., Huang M.H., and Hu D.H. Transplant of cultured autologous pure melanocytes after laser-abrasion for the treatment of segmental vitiligo. J. Dermatol. 27 (2000) 434-439
4. Chen Y.F., Yang P.Y., Hu D.N., Kuo F.S., Hung C.S., and Hung C.M. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases. J. Am. Acad. Dermatol. 51 1 Pt 1 (2004) 68-74
5. Chu S.C., Hu D.N., Yang S.F., Yang P.Y., Hsieh Y.S., Huang S.M., Yu G., and McCormick S.A. Uveal melanocytes produce matrix metalloproteinases-2 and -9 in vitro. Pigment Cell Res. 17 (2004) 636-642
6. Cohen Y., Goldenberg-Cohen N., Parrella P., Chower I., Merbs S.L., Pe'er J., and Sidransky D. Lack of BRAF mutation in primary uveal melanoma. Invest. Ophthalmol. Vis. Sci. 44 (2003) 2876-2878
7. Cruz III F., Rubin B.P., Wilson D., Town A., Schroeder A., Haley A., Bainbridge T., Heinrich M.C., and Corless C.L. Absence of BRAF and NRAS mutations in uveal melanoma. Cancer Res. 63 (2003) 5761-5766
8. van Dorp A.G., Verhoeven M.C., Nat-Van Der Meij T.H., Koerten H.K., and Ponec M. A modified culture system for epidermal cells for grafting purposes: an in vitro and in vivo study. Wound Repair Regen. 7 (1999) 214-225
9. Edmunds S.C., Cree I.A., Di Nicolantonio F., Hungerford J.L., Hurren J.S., and Kelsell D.P. Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas. Br. J. Cancer 88 (2003) 1403-1405
10. Espana E.M., Romano A.C., Kawakita T., Di Pascuale M., Smiddy R., and Tseng S.C. Novel enzymatic isolation of an entire viable human limbal epithelium sheet. Invest. Ophthalmol. Vis. Sci. 44 (2003) 4275-4281
11. Gear H., Williams H., Kemp E.G., and Roberts F. BRAF mutations in conjunctival melanoma. Invest. Ophthalmol. Vis. Sci. 45 (2004) 2484-2488
12. Geggel H.S., and Gipson I.K. Removal of viable sheets of conjunctival epithelium with dispase II. Invest. Ophthalmol. Vis. Sci. 26 (1985) 15-22
13. Goldenberg-Cohen N., Cohen Y., Rosenbaum E., Herscovici Z., Chowers I., Weinberger D., Pe'er J., and Sidransky D. T1799A BRAF mutations in conjunctival melanocytic lesions. Invest. Ophthalmol. Vis. Sci. 46 (2005) 3027-3030
14. Halaban R., and Alfano F.B. Selective elimination of fibroblasts from cultures of normal human melanocytes. In Vitro 20 (1984) 447-450
15. Heegaard S., Jensen O.A., and Prause J.U. Immunohistochemical diagnosis of malignant melanoma of the conjunctiva and uvea: comparison of the novel antibody against melan-A with S100 protein and HMB-45. Melanoma Res. 10 (2000) 350-354
16. Hu D.N., Ritch R., McCormick S.A., and Peltron-Henrion K. Isolation and cultivation of human iris pigment epithelium. Invest. Ophthalmol. Vis. Sci. 33 (1992) 2443-2453
17. Hu D.N., McCormick S.A., Ritch R., and Pelton-Henrion K. Studies of human uveal melanocytes in vitro: isolation, purification and cultivation of human uveal melanocytes. Invest. Ophthalmol. Vis. Sci. 34 (1993) 2210-2219
18. Hu D.N., McCormick S.A., and Ritch R. Studies of human uveal melanocytes in vitro: growth regulation of cultured human uveal melanocytes. Invest. Ophthalmol. Vis. Sci. 34 (1993) 2220-2227
19. Hu D.N., McCormick S.A., Orlow S.J., Rosemblat S., Lin A.Y., and Wo K. Melanogenesis by human uveal melanocytes in vitro. Invest. Ophthalmol. Vis. Sci. 36 (1995) 931-938
20. Hu D.N., McCormick S.A., Orlow S.J., Rosemblat S., and Lin A.Y. Regulation of melanogenesis by human uveal melanocytes in vitro. Exp. Eye Res. 64 (1997) 397-404
21. Hu D.N. Regulation of growth and melanogenesis of uveal melanocytes. Pigment Cell Res. 13 Suppl. 8 (2000) 81-86
22. Hu D.N., Woodward D.F., and McCormick S.A. Influence of autonomic neurotransmitters on human uveal melanocytes in vitro. Exp. Eye Res. 71 (2000) 217-224
23. Hu D.N., and McCormick S.A. Biochemical pathways: differential gene expression and cellular pathways determining tumor phenotype, comparison of uveal melanocytes and uveal melanoma cells in vitro. In: Albert D.M., and Polans A. (Eds). Ocular Oncology (2003), Marcel Dekker, Inc., New York 189-210
24. Hu D.N. Photobiology of ocular melanocytes and melanoma. Photochem. Photobiol. 81 (2005) 506-509
25. Inskip P., Devesa S., and Fraumeni Jr. J.F. Trends in incidence of ocular melanoma in the United States. Cancer Causes Control 14 (2003) 251-257
26. Ishii K., Harada R., Matsuo I., Shirakata Y., Hashimoto K., and Amagai M. In vitro keratinocyte dissociation assay for evaluation of the pathogenicity of anti-desmoglein 3 lgG autoantibodies in pemphigus vulgaris. J. Invest. Dermatol. 124 (2005) 939-946
27. Iwamoto S., Burrows R.C., Grossniklaus H.E., Orcutt J., Kalina R.E., Boehm M., Bothwell M.A., and Schmidt R. Immunophenotype of conjunctival melanomas: comparisons with uveal and cutaneous melanomas. Arch. Ophthalmol. 120 (2002) 1625-1629
28. Koizumi N., Cooper L.J., Fullwood N.J., Nakamura T., Inoki K., Tsuzuki M., and Kinoshita S. An evaluation of cultivated corneal limbal epithelial cells, using cell-suspension culture. Invest. Ophthalmol. Vis. Sci. 43 (2002) 2114-2121
29. Pena-Cruz V., Ito S., Oukka M., Yoneda K., Dascher C.C., Von Lichtenberg F., and Sugita M. Extraction of human Langerhans cells: a method for isolation of epidermis-resident dendritic cells. J. Immunol. Methods 255 (2001) 83-91
30. Rimoldi D., Salvi S., Lienard D., Lejeune F.J., Speiser D., Zografos L., and Cerottini J.C. Lack of BRAF mutations in uveal melanomas. Cancer Res. 63 (2003) 5712-5715
31. Ryder M.I., and Weinreb R.N. Cytokeratin patterns in corneal, limbal, and conjunctival epithelium. An immunofluorescence study with PKK-1, 8.12, 8.60, and 4.62 anticytokeratin antibodies. Invest. Ophthalmol. Vis. Sci. 31 (1990) 2230-2234
32. Seregard S., and Kock E. Conjunctival malignant melanoma in Sweden 1969-91. Acta Ophthalmol. 70 (1992) 289-296
33. Seregard S. Conjunctival melanoma. Surv. Ophthalmol. 42 (1998) 321-350
34. Shields C., Fasiudden A., Mashayekhi A., and Shields J. Conjunctival nevi: clinical features and natural course in 410 consecutive patients. Arch. Ophthalmol. 122 (2004) 167-175
35. Singh A.D., and Topham A. Incidence of uveal melanoma in the United States:1973-1997. Ophthalmology 110 (2003) 956-961
36. Spendlove H.E., Damato B.E., Humphreys J., Barker K.T., Hiscott P.S., and Houlston R.S. BRAF mutations are detectable in conjunctival but not uveal melanomas. Melanoma Res. 14 (2004) 449-452
37. Stang A., Parkin D.M., Ferlay J., and Jockel K.H. International uveal melanoma incidence trends in view of a decreasing proportion of morphological verification. Int. J. Cancer 114 (2005) 114-123
38. Tuomaala S., Eskelin S., Tarkkanen A., and Kivela T. Population-based assessment of clinical characteristics predicting outcome of conjunctival melanoma in whites. Invest. Ophthalmol. Vis. Sci. 43 (2002) 3399-3408
39. Wang Y., Hu D.N., McCormick S.A., Savage H.E., and O'Rourke J. Tissue plasminogen activator is released into cultured medium by cultured human uveal melanocytes. Pigment Cell Res. 15 (2002) 373-378
40. Yu G.P., Hu D.N., McCormick S., and Finger P. Conjunctival melanoma: is it increasing in the United States?. Am. J. Ophthalmol. 135 (2003) 800-806
41. Zito-Abbad E., Borderie V.M., Baudrimont M., Bourcier T., Laroche L., Chapel C., and Uzel J.L. Corneal epithelial cultures generated from organ-cultured limbal tissue: factors influencing epithelial cell growth. Curr. Eye Res. 31 (2006) 391-399